Clinical Trials Browser

Phase 1/2 × Neoplasm Metastasis × temsirolimus × Clear all

NCT01020305 2014-10-13

Temsirolimus to Reverse Androgen Insensitivity for Castration-resistant Prostate Cancer

Phase 1/2 Terminated

5 enrolled 6 charts

Neoplasm Metastasis, Prostatic Neoplasms